StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) income statement

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3049% above fair value
$51.96+4.67 (+9.88%)

Close on Nov 18, 2026Market cap $1.55BP/E –Yield –

GeneDx Holdings Corp. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
69.4%
Operating margin
-20.3%
Net margin
-23.4%
Return on equity, FY2025
-7.6%

Financial strength

Current ratio
3.30
Debt to equity
0.40
Debt to assets
20.1%
Cash to current liabilities
80.8%

Valuation

P/E ratio
–
Price to sales
3.41
Price to book
6.34
Dividend yield
–

See a number that looks wrong?